G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 13.53 CNY -1.24% Market Closed
Market Cap: 5.5B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

GemPharmatech Co Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GemPharmatech Co Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
G
GemPharmatech Co Ltd
SSE:688046
Common Shares Outstanding
ÂĄ410m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Common Shares Outstanding
ÂĄ2.9B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Common Shares Outstanding
ÂĄ1.8B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Common Shares Outstanding
ÂĄ4.2B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Common Shares Outstanding
ÂĄ861.5m
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
3%
W
WuXi XDC Cayman Inc
HKEX:2268
Common Shares Outstanding
ÂĄ1.2B
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GemPharmatech Co Ltd
Glance View

Market Cap
5.5B CNY
Industry
Life Sciences Tools & Services

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Intrinsic Value
21.04 CNY
Undervaluation 36%
Intrinsic Value
Price
G

See Also

What is GemPharmatech Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
410m CNY

Based on the financial report for Dec 31, 2023, GemPharmatech Co Ltd's Common Shares Outstanding amounts to 410m CNY.

What is GemPharmatech Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
0%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top